KUC-7483

DRUG3 trials

Sponsors

Kissei Pharmaceutical Co., Ltd.

Conditions

Overactive BladderOveractive Bladder (OAB)

Phase 2

A Phase II Study of KUC-7483 in Patients With Overactive Bladder

CompletedNCT00742833

Kissei Pharmaceutical Co., Ltd.Overactive Bladder (OAB)

Target: 400Updated: 2009-09-04

Phase 3

Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

WithdrawnNCT01003405

Kissei Pharmaceutical Co., Ltd.Overactive Bladder

Target: 100Updated: 2010-07-27

A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

CompletedNCT01004315

Kissei Pharmaceutical Co., Ltd.Overactive Bladder

Target: 750Updated: 2010-07-27